← All trials
NCT06712641
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2025
- Primary completion
- Jun 30, 2028
- Completion date
- May 31, 2033
- First posted
- Dec 2, 2024
- Last posted
- Dec 2, 2024
- Enrollment
- 1940
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Oslo Metropolitan UniversityLead sponsor
- University of OsloCollaborator
- Oslo Metropolitan UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.